2 weeks Ago By Defense World Staff
Townsquare Capital LLC raised its position in Waters Co. ( NYSE:WAT – Free Report ) by 95.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor owned 1,244 shares of the medical instruments supplier’s stock after purchasing an additional 609 shares during the period. Townsquare Capital LLC’s holdings in Waters were worth $462,000 at the end of the most recent reporting period. Other hedge funds also recently modified their holdings of the company.
Sterling Capital Management LLC lifted its stake in shares of Waters by 27.0% during the fourth quarter. Sterling Capital Management LLC now owns 1,944 shares of the medical instruments supplier’s stock valued at $721,000 after buying an additional 413 shares during the period.
Argent Trust Co lifted its stake in shares of Waters by 19.4% during the 4th quarter. Argent Trust Co now owns 1,005 shares of the medical instruments supplier’s stock worth $373,000 after purchasing an additional 163 shares during the period.
Neuberger Berman Group LLC boosted its holdings in shares of Waters by 9.7% during the fourth quarter. Neuberger Berman Group LLC now owns 3,754 shares of the medical instruments supplier’s stock worth $1,393,000 after purchasing an additional 331 shares during the last quarter.
Bessemer Group Inc. grew its position in shares of Waters by 0.9% in the fourth quarter.
Bessemer Group Inc. now owns 20,427 shares of the medical instruments supplier’s stock valued at $7,578,000 after purchasing an additional 190 shares during the period. Finally, APG Asset Management US Inc.
acquired a new position in Waters in the fourth quarter valued at $455,000. 94.01% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets WAT has been the topic of a number of research analyst reports. Barclays decreased their price target on Waters from $400.00 to $350.
00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. Baird R W upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 26th. UBS Group increased their price target on shares of Waters from $405.
00 to $410.00 and gave the stock a “neutral” rating in a research note on Thursday, February 13th. Robert W.
Baird raised shares of Waters from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $396.00 to $407.00 in a research note on Wednesday, March 26th.
Finally, JPMorgan Chase & Co. increased their target price on Waters from $380.00 to $390.
00 and gave the stock a “neutral” rating in a research report on Thursday, March 6th. Ten investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $395.
38. Waters Price Performance WAT opened at $320.90 on Monday.
Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.
56. The firm has a market cap of $19.09 billion, a price-to-earnings ratio of 29.
96, a PEG ratio of 3.79 and a beta of 1.04.
The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.
14. The company has a fifty day simple moving average of $360.29 and a 200 day simple moving average of $371.
34. Waters ( NYSE:WAT – Get Free Report ) last announced its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.
10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08.
Waters had a return on equity of 46.31% and a net margin of 21.56%.
Equities research analysts expect that Waters Co. will post 12.86 EPS for the current fiscal year.
Waters Profile ( Free Report ) Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also Five stocks we like better than Waters Pros And Cons Of Monthly Dividend Stocks With a 60%+ Upside, There’s Plenty to Love About Lovesac How the NYSE and NASDAQ are Different, Why That Matters to Investors J.B. Hunt Transport Overcorrects Into a Buying Opportunity What is a Dividend Harvesting Strategy and How Can Investors Profit from it? AppLovin: Can Record Profits Overcome Market Skepticism? Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Waters Co. ( NYSE:WAT – Free Report ). Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.
com's FREE daily email newsletter ..
